1993-2017年澳大利亚心肌梗死与冠状动脉血运重建趋势
该研究分析1993至2017年澳大利亚全国心肌梗死住院与冠状动脉手术趋势及经济负担,发现经人口调整后心梗年发病率从216.2/10万升至2007年峰值270.4后降至2017年218.7,NSTEMI与STEMI呈相反趋势,血运重建手术增加但CABG下降,住院费用翻倍。
要点
- 经人口调整后心梗总发病率在2007年达峰后下降,提示上升趋势已稳定。
- NSTEMI发病率显著上升而STEMI持续下降,两者趋势相反。
- 冠脉造影与PCI逐年增加,CABG逐年减少,住院费用增加100%。
核心结论
- 澳大利亚心梗住院发病率上升趋势似已稳定,但相关医疗支出仍显著,需持续实施公共卫生政策与预防策略。
研究设计与样本
- 基于澳大利亚全国住院数据的回顾性趋势分析,主要结局为1993至2017年总心梗、STEMI和NSTEMI住院发病率及时间趋势,同时收集冠状动脉手术和住院费用。
主要发现
- 经人口变化调整后,心梗年发病率从216.2例/10万升至2007年峰值270.4例/10万,随后降至2017年218.7例/10万。
- NSTEMI发病率从1993年68.0例/10万升至2007年峰值192.6例/10万,后降至2017年162.6例/10万。
- STEMI发病率从1993年148.3例/10万降至2017年56.2例/10万。
- 研究期间心梗住院年增长0.7%,NSTEMI住院年增长5.6%,STEMI住院年下降4.8%。
- 冠脉造影和PCI分别年增长3.4%和3.3%,CABG年下降2.2%;心梗住院费用增加100%,平均住院时间缩短45%。
临床怎么用
- 关注NSTEMI发病率上升及STEMI下降的流行病学转变,优化相应诊疗资源配置。
- 尽管心梗总发病率趋稳,仍需重视持续增长的医疗费用和预防策略的实施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Prior data have shown rising acute myocardial infarction (MI) trends in Australia; whether these increases have continued in recent years is not known. This study thus sought to characterise contemporary nationwide trends in MI hospitalisations and coronary procedures in Australia and their associated economic burden. METHODS: The primary outcome measure was the incidence and time trends of total MI, ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) hospitalisations from 1993 to 2017. The incidence and time trends of coronary procedures were additionally collected, alongside MI hospitalisation costs. RESULTS: Adjusted for population changes, annual MI incidence increased from 216.2 cases per 100 000 to a peak of 270.4 in 2007 with subsequent decline to 218.7 in 2017. Similarly, NSTEMI incidence increased from 68.0 cases per 100 000 in 1993 to a peak of 192.6 in 2007 with subsequent decline to 162.6 in 2017. STEMI incidence decreased from 148.3 cases per 100 000 in 1993 to 56.2 in 2017. Across the study period, there were annual increases in MI hospitalisations of 0.7% and NSTEMI hospitalisations of 5.6%, and an annual decrease in STEMI hospitalisations of 4.8%. Angiography and percutaneous coronary intervention increased by 3.4% and 3.3% annually, respectively, while coronary artery bypass graft surgery declined by 2.2% annually. MI hospitalisation costs increased by 100% over the study period, despite a decreased average length of stay by 45%. CONCLUSIONS: The rising incidence of MI hospitalisations appear to have stabilised in Australia. Despite this, associated healthcare expenditure remains significant, suggesting a need for continual implementation of public health policies and preventative strategies.
引用
- Lin, Gallagher, Tu, et al. Trends in myocardial infarction and coronary revascularisation procedures in Australia, 1993-2017. Heart. 2023. PMID: 36344268. doi:10.1136/heartjnl-2022-321393
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。